Harvard T.H. Chan School of Public Health, Boston, MA
BA, Human Biology
Claremont McKenna College, Claremont, CA
Alison Kawai is a Director of Epidemiology at RTI-HS with 11 years' experience as a pharmacoepidemiologist. She is experienced in the use of secondary data to assess the utilization and safety of medications and vaccines. She has worked extensively in multi-site collaborations with data from electronic health records and claims, medical records and public health registries. She has worked in a range of therapeutic and disease areas, with substantial expertise in vaccine safety and in pregnancy safety studies. At RTI-HS, she provides scientific leadership and epidemiology expertise in the planning, design, and execution of studies.
Before coming to RTI-HS, Dr. Kawai was a Research Scientist and Principal Associate in the Department of Population Medicine at Harvard Pilgrim Health Care Institute and Harvard Medical School, where she was an investigator within the Sentinel Program and the Vaccine Safety Datalink Project, two federally-funded postmarket safety surveillance systems that incorporate data from several health insurers across the US with the use of distributed databases. While there, she worked primarily on studies to evaluate vaccine safety in pregnant women and pediatric populations, as well as on infrastructure activities to develop methods and data capabilities to conduct these and other postmarketing safety studies. Dr. Kawai received her master’s and doctorate degrees from the Harvard Chan School of Public Health.